Loading
Latest filing published 18 Aug 2026 for Xtant Medical Holdings, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Scott C. Neils is a declared insider of Xtant Medical Holdings, Inc. (finance chief), with filings sourced from SEC (Form 4). Between 15 January 2022 and 15 August 2026, the trades on record add up to 16 filings.
The open-market record consists of 3 sales worth €7,908, with no purchase. Outside the open market, there are 13 share grants.
Most recently, on 18 August 2026, the filings show a share grant in Xtant Medical Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations